This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cummings, K. L.
Right arrow Articles by Tarleton, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cummings, K. L.
Right arrow Articles by Tarleton, R. L.

 Previous Article  |  Next Article 

Infection and Immunity, July 2004, p. 4081-4089, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4081-4089.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice

Kara L. Cummings and Rick L. Tarleton*

Center for Tropical and Emerging Global Diseases and Department of Cellular Biology, University of Georgia, Athens, Georgia 30602

Received 7 January 2004/ Returned for modification 17 February 2004/ Accepted 27 March 2004

Immune control of many intracellular pathogens, including Trypanosoma cruzi, is reported to be dependent on the production of nitric oxide. In this study, we show that mice deficient in inducible nitric oxide synthase (iNOS or NOS2) exhibit resistance to T. cruzi infection that is comparable to that of wild-type mice. This is the case for two iNOS-deficient mouse strains, Nos2tm1Lau and Nos2 N5, infected with the Brazil or Tulahuen strain of T. cruzi. In all cases, blood parasitemia, tissue parasite load, and survival rates are similar between wild-type and iNOS-deficient mice. In contrast, both wild-type and Nos2tm1Lau mice died within 32 days postinfection when treated with the nitric oxide synthase inhibitor aminoguanidine. Increased transcription of NOS1 or NOS3 is not found in iNOS-knockout (KO) mice, indicating that the absence of nitric oxide production through iNOS is not compensated for by increased production of other NOS isoforms. However, Nos2tm1Lau mice exhibit enhanced expression of tumor necrosis factor alpha, interleukin-1, and macrophage inflammatory protein 1{alpha} compared to that of wild-type mice, and these alterations may in part compensate for the lack of iNOS. These results clearly show that iNOS is not required for control of T. cruzi infection in mice.


* Corresponding author. Mailing address: Center for Tropical and Emerging Global Diseases, 623 Biological Sciences Building, University of Georgia, Athens, GA 30602. Phone: (706) 542-3362. Fax: (706) 542-4271. E-mail: tarleton{at}cb.uga.edu.

Editor: W. A. Petri, Jr.


Infection and Immunity, July 2004, p. 4081-4089, Vol. 72, No. 7
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.7.4081-4089.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ny, L., Li, H., Mukherjee, S., Persson, K., Holmqvist, B., Zhao, D., Shtutin, V., Huang, H., Weiss, L. M., Machado, F. S., Factor, S. M., Chan, J., Tanowitz, H. B., Jelicks, L. A. (2008). A Magnetic Resonance Imaging Study of Intestinal Dilation in Trypanosoma cruzi-infected Mice Deficient in Nitric Oxide Synthase. Am J Trop Med Hyg 79: 760-767 [Abstract] [Full Text]  
  • Appelberg, R. (2006). Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 79: 1117-1128 [Abstract] [Full Text]  
  • Santiago, H. C., Feng, C. G., Bafica, A., Roffe, E., Arantes, R. M., Cheever, A., Taylor, G., Vierira, L. Q., Aliberti, J., Gazzinelli, R. T., Sher, A. (2005). Mice Deficient in LRG-47 Display Enhanced Susceptibility to Trypanosoma cruzi Infection Associated with Defective Hemopoiesis and Intracellular Control of Parasite Growth. J. Immunol. 175: 8165-8172 [Abstract] [Full Text]